Peru recorded one of its worst dengue outbreaks on record in early 2026. Stanford researchers published findings in March tracing the crisis directly to extreme weather patterns. If you want a preview of what climate-driven dengue looks like when it arrives in a country unprepared, Peru is the case study.
The question for the United States is not whether dengue will become more common here. It will. The question is whether the country will spend now on prevention or spend far more later on crisis response.
The Mosquito Does Not Care About Your Politics
Aedes aegypti, the primary dengue vector, has been documented in at least 30 US states. It does not need tropical conditions. It needs warm summers, standing water, and dense human populations. Climate change is extending the warm season in places like Texas, Florida, and Arizona, which already report local dengue transmission. A 2024 global total of 14 million dengue cases and more than 11,000 deaths makes clear that this disease scales fast when vector populations go uncontrolled.
The honest concession to skeptics is this: the US has real structural advantages. Higher GDP per capita correlates with a 35% reduction in dengue fatality rates in countries where the data is solid. American hospitals can manage severe dengue far better than overstretched clinics in Pakistan, which saw 33,394 lab-confirmed cases in 2025, up from 21,016 just 2 years earlier. Wealth buys clinical capacity.
But wealth does not automatically buy surveillance infrastructure, and that is where the US is exposed. The Caribbean's CariVecNet framework, developed in 2025, specifically flagged the danger of funding droughts between outbreaks. The pattern is consistent: agencies treat dengue as an emergency response problem rather than a steady-state management problem. When transmission drops, budgets follow. When the next outbreak hits, the monitoring systems needed to catch it early have been quietly defunded.
The Infrastructure Gap Is the Real Risk
The US does not need to fear becoming Peru or Pakistan. But it does need to fear becoming Miami in 2024, where local dengue transmission occurred and the public health response was reactive rather than proactive. Reactive is expensive. The CDC's vector surveillance programs are underfunded relative to the threat, and wastewater monitoring for dengue, which Caribbean health authorities are actively building into outbreak-detection frameworks, barely exists at the federal level in the US.
One complication worth flagging: a new study on PM2.5 pollution and dengue fatality rates found that countries with annual mean PM2.5 above 35 micrograms per cubic meter had 3 to 5 times higher dengue death rates than cleaner-air countries. That finding is real but it creates a resource allocation trap. Sunil, an expert cited in the study, warned directly that folding air quality control into dengue strategy risks pulling funding from vector control, which remains the most effective intervention. The US should clean its air for many reasons. It should not treat that as a dengue strategy.
What the US actually needs is straightforward, if politically unglamorous: year-round vector surveillance in the South and Southwest, expanded wastewater monitoring for dengue markers, and a federal commitment to fund those programs between outbreaks, not only during them. Latin America recorded 4.4 million dengue cases in 2025, down 66% from the prior year. That drop shows control is possible. It requires sustained investment, not crisis funding.
The dengue threat to the US is real, manageable, and almost certainly being underestimated by every administration that has not yet faced an outbreak on its watch. That streak will not last.
